Financials Lenzing AG London S.E.

Equities

0NCV

AT0000644505

Specialty Chemicals

Market Closed - London S.E. 11:30:00 2024-04-26 am EDT 5-day change 1st Jan Change
30.15 EUR +0.17% Intraday chart for Lenzing AG +1.53% -15.19%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,198 2,198 3,239 1,455 1,373 1,162 - -
Enterprise Value (EV) 1 2,608 2,681 4,227 1,455 1,373 2,976 3,027 2,805
P/E ratio 17.9 x 345 x 29.3 x -19.9 x -1.78 x -19.2 x 56.4 x 19.2 x
Yield 1.21% - 3.57% - - 1.26% 2.49% 9.47%
Capitalization / Revenue 1.04 x 1.35 x 1.48 x 0.57 x 0.54 x 0.44 x 0.43 x 0.41 x
EV / Revenue 1.24 x 1.64 x 1.93 x 0.57 x 0.54 x 1.13 x 1.11 x 0.98 x
EV / EBITDA 7.98 x 13 x 11.6 x 6.01 x 4.53 x 7.93 x 6.28 x 5.22 x
EV / FCF 4,304 x -4.33 x -9.39 x - - 59.4 x 26.7 x 19.8 x
FCF Yield 0.02% -23.1% -10.7% - - 1.68% 3.75% 5.06%
Price to Book 1.45 x 1.27 x 1.56 x - - 1.01 x 0.98 x 0.62 x
Nbr of stocks (in thousands) 26,550 26,550 26,550 26,550 38,618 38,620 - -
Reference price 2 82.80 82.80 122.0 54.80 35.55 30.10 30.10 30.10
Announcement Date 1/28/20 3/11/21 3/10/22 3/9/23 3/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,105 1,633 2,195 2,566 2,521 2,623 2,729 2,865
EBITDA 1 327 206.9 362.9 241.9 303.3 375.5 481.8 537.7
EBIT 1 162.3 48.44 200.6 16.5 -476.4 125.6 216.8 284.4
Operating Margin 7.71% 2.97% 9.14% 0.64% -18.9% 4.79% 7.94% 9.92%
Earnings before Tax (EBT) 1 163.8 22.25 182.9 -45.9 -585.6 7 112.2 146
Net income 1 114 6.277 110.3 -73.1 -649.4 -60.5 20.57 60.5
Net margin 5.42% 0.38% 5.03% -2.85% -25.76% -2.31% 0.75% 2.11%
EPS 2 4.630 0.2400 4.160 -2.750 -20.02 -1.565 0.5333 1.565
Free Cash Flow 1 0.606 -619.8 -450.3 - - 50.1 113.5 142
FCF margin 0.03% -37.96% -20.52% - - 1.91% 4.16% 4.96%
FCF Conversion (EBITDA) 0.19% - - - - 13.34% 23.56% 26.41%
FCF Conversion (Net income) 0.53% - - - - - 551.86% 234.71%
Dividend per Share 2 1.000 - 4.350 - - 0.3800 0.7500 2.850
Announcement Date 1/28/20 3/11/21 3/10/22 3/9/23 3/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 555.2 615 678.6 676.5 595.5 623.1 627.1 615.5 655.4 -
EBITDA 1 79.8 88 100.9 74.1 -21 29.7 106.8 82.6 84.22 73
EBIT 39.3 - 52 16.9 -96.1 -41.4 29.4 1.5 -465.9 -
Operating Margin 7.08% - 7.66% 2.5% -16.14% -6.64% 4.69% 0.24% -71.09% -
Earnings before Tax (EBT) 35.9 - - - - - - - - -
Net income 18.8 - 39.7 - -130.4 -80.5 -23.7 -44.3 - -
Net margin 3.39% - 5.85% - -21.9% -12.92% -3.78% -7.2% - -
EPS 0.7100 - 1.490 - - -3.030 -0.8900 -0.9700 - -
Dividend per Share - - - - - - - - - -
Announcement Date 11/3/21 5/4/22 8/3/22 11/3/22 3/9/23 5/3/23 8/2/23 11/3/23 3/15/24 -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 410 482 988 - - 1,813 1,865 1,643
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.254 x 2.332 x 2.722 x - - 4.829 x 3.87 x 3.055 x
Free Cash Flow 1 0.61 -620 -450 - - 50.1 114 142
ROE (net income / shareholders' equity) 8.15% 0.39% 6.11% - - -5.95% 2.77% 5.45%
ROA (Net income/ Total Assets) 4.27% - - - - 0.13% 1.61% 2.58%
Assets 1 2,670 - - - - -46,081 1,280 2,346
Book Value Per Share 2 57.00 65.30 78.00 - - 29.90 30.60 48.50
Cash Flow per Share 2 9.210 1.840 14.80 - - 2.050 10.90 22.50
Capex 1 244 669 844 - - 236 244 247
Capex / Sales 11.59% 40.96% 38.47% - - 8.99% 8.94% 8.63%
Announcement Date 1/28/20 3/11/21 3/10/22 3/9/23 3/15/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
30.1 EUR
Average target price
32.26 EUR
Spread / Average Target
+7.18%
Consensus